This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Feb 12;51(6):643-4.

doi: 10.1016/j.jacc.2007.10.033.

The Yin and Yang of high-density lipoprotein cholesterol

PMID: 18261683
DOI: 10.1016/j.jacc.2007.10.033

Free article

Review

The Yin and Yang of high-density lipoprotein cholesterol

Jacques Genest. J Am Coll Cardiol. 2008.

Free article

. 2008 Feb 12;51(6):643-4.

doi: 10.1016/j.jacc.2007.10.033.

Author

PMID: 18261683
DOI: 10.1016/j.jacc.2007.10.033

No abstract available

PubMed Disclaimer

Comment on

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJ. van der Steeg WA, et al. J Am Coll Cardiol. 2008 Feb 12;51(6):634-42. doi: 10.1016/j.jacc.2007.09.060. J Am Coll Cardiol. 2008. PMID: 18261682 Clinical Trial.

Similar articles

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.
Faergeman O. Faergeman O. J Intern Med. 2006 May;259(5):434-6. doi: 10.1111/j.1365-2796.2006.01650.x. J Intern Med. 2006. PMID: 16629848 Review. No abstract available.
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
Grover SA, Kaouache M, Joseph L, Barter P, Davignon J. Grover SA, et al. Arch Intern Med. 2009 Oct 26;169(19):1775-80. doi: 10.1001/archinternmed.2009.328. Arch Intern Med. 2009. PMID: 19858435
High-density lipoprotein cholesterol: current perspective for clinicians.
Whayne TF Jr. Whayne TF Jr. Angiology. 2009 Oct-Nov;60(5):644-9. doi: 10.1177/0003319709331392. Epub 2009 Feb 23. Angiology. 2009. PMID: 19240106 Review.
Is high-density lipoprotein cardioprotective or simply a marker of cardiovascular disease?
Mooradian AD. Mooradian AD. Am J Ther. 2014 Sep-Oct;21(5):438-9. doi: 10.1097/MJT.0b013e3182838e47. Am J Ther. 2014. PMID: 23528372 No abstract available.
[HDL cholesterol].
Kanehara H, Oida K. Kanehara H, et al. Nihon Rinsho. 2004 Dec;62 Suppl 12:14-7. Nihon Rinsho. 2004. PMID: 15658251 Review. Japanese. No abstract available.

See all similar articles

Cited by

Limitations of a Cardiac Risk (QRISK2) Calculator in Patients with High Density Lipoprotein (HDL).
Minhas JS, Patel P, Gupta PK. Minhas JS, et al. High Blood Press Cardiovasc Prev. 2016 Mar;23(1):47-50. doi: 10.1007/s40292-016-0131-x. Epub 2016 Feb 23. High Blood Press Cardiovasc Prev. 2016. PMID: 26905417
Serum HDL-C level of Iranian adults: results from sixth national Surveillance of Risk Factors of Non-Communicable Disease.
Hosseini M, Navidi I, Yousefifard M, Heshmat R, Koohpayehzadeh J, Asgari F, Etemad K, Rafei A, Gouya MM. Hosseini M, et al. J Diabetes Metab Disord. 2014 Jun 16;13:67. doi: 10.1186/2251-6581-13-67. eCollection 2014. J Diabetes Metab Disord. 2014. PMID: 25028645 Free PMC article.
Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico.
Mendez MA, González-Horta C, Sánchez-Ramírez B, Ballinas-Casarrubias L, Cerón RH, Morales DV, Terrazas FA, Ishida MC, Gutiérrez-Torres DS, Saunders RJ, Drobná Z, Fry RC, Buse JB, Loomis D, García-Vargas GG, Del Razo LM, Stýblo M. Mendez MA, et al. Environ Health Perspect. 2016 Jan;124(1):104-11. doi: 10.1289/ehp.1408742. Epub 2015 Jun 12. Environ Health Perspect. 2016. PMID: 26068977 Free PMC article.
Association between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals.
Li Y, Li Y, Meng L, Zheng L. Li Y, et al. PLoS One. 2015 Jan 5;10(1):e112281. doi: 10.1371/journal.pone.0112281. eCollection 2015. PLoS One. 2015. PMID: 25559358 Free PMC article.
Low high-density lipoprotein cholesterol: current status and future strategies for management.
Singh V, Sharma R, Kumar A, Deedwania P. Singh V, et al. Vasc Health Risk Manag. 2010 Oct 29;6:979-96. doi: 10.2147/VHRM.S5685. Vasc Health Risk Manag. 2010. PMID: 21127701 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information